Polypharmacy in RA patients is linked to increased drug interaction risks, especially with immunosuppressants, necessitating careful management and monitoring. Older age and multiple comorbidities are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback